Cardiovascular Nanomedicines: A Review of Nanoparticle-Mediated Strategies for Disease Treatment

Kalyani Dhatadak¹, Pragati Bhalerao¹, Sakshi Soni¹, Manojkumar Mahajan², Aman Upaganlawar³, Chandrashekhar Upasani⁴

Keywords: Cardiovascular diseases, targeted drug delivery, nanoparticles, ischemic heart diseases, myocardial infarction

DOI: 10.63475/yjm.v4i2.0016

DOI URL: https://doi.org/10.63475/yjm.v4i2.0016

Publish Date: 22-09-2025

Download PDF

Pages: 204 - 213

Views: 2

Downloads: 4

Citation: 0

Author Affiliation:

1 Research Scholar, Department of Pharmacology, SNJBs Shriman Sureshdada Jain College of Pharmacy, Chandwad, Nashik, India
2 Associate Professor, Department of Pharmacology, SNJBs Shriman Sureshdada Jain College of Pharmacy, Chandwad, Nashik, India
3 Professor and Head, Department of Pharmacology, SNJBs Shriman Sureshdada Jain College of Pharmacy, Chandwad, Nashik, India
4 Professor and Principal, SNJBs Shriman Sureshdada Jain College of Pharmacy, Chandwad, Nashik, India

Abstract

Worldwide, cardiovascular diseases (CVDs) are the leading cause of mortality, demanding innovative therapeutic strategies. Nanomedicine offers promising solutions through nanoparticle-mediated drug delivery, enhancing precision, efficacy, and safety. This review examines nanocarriers, including liposomes, polymeric nanoparticles, and dendrimers, for targeted CVD treatment, encompassing coronary artery disease, atherosclerosis, and myocardial infarction. This review highlights advances in theranostics, gene therapy, and stimuli-responsive systems while addressing challenges related to biocompatibility and clinical translation. Nanotechnology holds transformative potential for CVD management, enabling personalized and least invasive treatments.

---